文献速递质量管理与危急值临床生化临床免疫

分析性能规范推导的最新模型:如何定义技术可达的最高分析性能水平

State-of-the-art model for derivation of analytical performance specifications: how to define the highest level of analytical performance technically achievable.
PubMed 文献 · Clin Chem Lab Med · 2024-02-05

本文讨论如何依据欧洲临床化学与检验医学联合会2014年米兰战略会议确立的三种模型推导测量不确定度的分析性能规范。作者以血清C反应蛋白和铁蛋白为例,描述当检验项目归属模型3时推导分析性能规范的理论前提与实验方案,模型3反映技术可达的最佳分析性能。

要点

  • 检验结果应溯源至更高等级参考物并满足临床用途所需的最大允许测量不确定度。
  • 当前共识支持用EFLM米兰会议三种模型之一推导分析性能规范。
  • 模型3反映技术可达的最佳分析性能,与临床结局无直接关系。

核心结论

  • 模型3可反映技术可达的最佳分析性能,据此可推导测量不确定度的分析性能规范。
  • 该模型虽与临床结局无直接关系,但可提供体外诊断医疗器械性能及结果平均质量的有用信息。

研究设计与样本

  • 本文为方法学论述,以血清C反应蛋白和铁蛋白为例描述模型3推导分析性能规范的理论前提与实验方案。

主要发现

  • 不同模型对特定检验项目的适用性不同,应优先关注项目的生物学与临床特征。
  • 模型3应反映技术可达的最佳分析性能。

关键数值与推荐

  • 当前共识支持采用欧洲临床化学与检验医学联合会2014年米兰战略会议确立的三种模型之一推导分析性能规范。
  • 实验室结果应溯源至更高等级参考物,其质量应满足适合预期临床用途的最大允许测量不确定度。

临床怎么用

  • 实验室人员应使用适当的分析性能规范估计并验证所执行检验的测量不确定度。
  • 对归属模型3的检验项目,可按本文所述理论前提与实验方案推导测量不确定度的分析性能规范。

局限性

  • 模型3与临床结局无直接关系。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

To be accurate and equivalent among assays, laboratory results should be traceable to higher-order references and their quality should fulfill maximum allowable measurement uncertainty (MU) as defined to fit the intended clinical use. Accordingly, laboratory professionals should estimate and validate MU of performed tests using appropriate analytical performance specifications (APS). Current consensus supports the derivation of APS by using one of the three models established by the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) Strategic Conference held in Milan in 2014. It is recognized that some models are better suited for certain measurands than for others and the attention should be primarily directed towards their biological and clinical characteristics. Among others, model 3 should reflect the state of the art of the measurements that can be defined as the best analytical performance that is technically achievable. Taking serum C-reactive protein and ferritin as examples, here we describe the theoretical premises and the experimental protocol to be used to derive APS for MU when a measurand is allocated to this model. Although the model lacks a direct relationship with clinical outcomes, useful information about the in vitro diagnostic medical device performance and the average quality of provided results may be obtained.

来源:Clin Chem Lab Med,查看原文。版权归原作者所有。

引用

  1. Borrillo F, Panteghini M. State-of-the-art model for derivation of analytical performance specifications: how to define the highest level of analytical performance technically achievable. Clin Chem Lab Med. 2024. PMID: 38353168. doi:10.1515/cclm-2023-1286

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。